Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis

Gene-modified mesenchymal stem cell (MSC)-like cells with enhanced bone marrow homing and osteogenesis have been used in treating glucocorticoid-induced murine osteoporosis (GIOP). Recent preclinical studies have further demonstrated the immunomodulatory and anticatabolic potential of allogeneic MSC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Sui, Bingdong, Hu, Chenghu, Zhang, Xinyi, Zhao, Pan, He, Tao, Zhou, Cuihong, Qiu, Xinyu, Chen, Nan, Zhao, Xinyi, Jin, Yan
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2016
Matèries:
Tissue Engineering and Regenerative Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4996443/
https://ncbi.nlm.nih.gov/pubmed/27365487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0347
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars